Pharmalot -- For several years, Charles Nemeroff assured Emory University, where he chaired the psychiatry department, that he wouldn’t accept more than $10,000 in consulting fees from Glaxo, since he was the primary investigator on an NIH-funded grant for research into a Glaxo drug.
